Restoration of general CD8 T cell function after therapeutic resolution of chronic HCV could have beneficial effects on the function of antigen-specific cells and help prevent complications associated with chronic HCV and cirrhosis, including HCC and other immune dysfunction. The gene discussed is CD8A; the disease is Cirrhosis.